These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 779410
21. [Phospholipids in the treatment of arteriosclerotic pathological mental deterioration (PMD)]. Bernardi S, Fanzago A. Minerva Med; 1966 Jul 07; 57(54):2461-4. PubMed ID: 5946882 [No Abstract] [Full Text] [Related]
22. Procaine (novocain) treatment of patients with senile and arteriosclerotic brain disease. KRAL VA, CAHN C, DEUTSCH M, MUELLER H, SOLYOM L. Can Med Assoc J; 1962 Nov 24; 87(21):1109-13. PubMed ID: 14035436 [Abstract] [Full Text] [Related]
23. [Changes in coagulographic indices of patients with cerebral atherosclerosis complicated by mental disorders during the treatment process]. Pavlova SI. Zh Nevropatol Psikhiatr Im S S Korsakova; 1980 Nov 24; 80(7):1016-9. PubMed ID: 7415719 [Abstract] [Full Text] [Related]
24. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis]. Schlesinger P. Rev Bras Med; 1972 Jan 24; 29(1):38-41. PubMed ID: 4552863 [No Abstract] [Full Text] [Related]
25. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients]. Petronio G, Scali G, Casa B, Nonis E. Clin Ter; 1980 Aug 31; 94(4):427-44. PubMed ID: 6257445 [No Abstract] [Full Text] [Related]
26. [Analysis of the efficiency of Gerigoa-depot in a double-blind study]. Jansen W. Med Welt; 1976 Jul 23; 27(30):1446-7. PubMed ID: 785152 [No Abstract] [Full Text] [Related]
27. [Clinical results of phosphatidylserine in 40 climacteric and elderly women with psycho-organic disorders]. Manfredi M, Pranteda G, Saccà A, Morrone G, Vita F, Pranteda G. Clin Ter; 1987 Jan 15; 120(1):33-6. PubMed ID: 2973854 [No Abstract] [Full Text] [Related]
28. Long-term anticoagulant therapy in patients with cerebral infarction. A crontrolled clinical study. Enger E, Boyesen S. Acta Med Scand Suppl; 1965 Jan 15; 438():1-61. PubMed ID: 5323519 [No Abstract] [Full Text] [Related]
29. Manifestations of cerebral arteriosclerosis unaffected by a vasodilator. Practitioner; 1969 Nov 15; 203(217):695-8. PubMed ID: 4391604 [No Abstract] [Full Text] [Related]
30. [Successes in novocain therapy in the control of premature ageing (author's transl)]. Zdichynec B. Z Alternsforsch; 1977 Nov 15; 32(3):267-9. PubMed ID: 337694 [Abstract] [Full Text] [Related]
31. [Clinical considerations on the use of an antispastic-antivagal drug association in the cholecysto-coronary syndrome]. Cristiano P, Panzitta S, Cuiuli V, Petronio A, Giraldi A. Minerva Gastroenterol; 1973 Nov 15; 19(4):259-69. PubMed ID: 4592525 [No Abstract] [Full Text] [Related]
32. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study]. Lefebvre P, Crocq L, Bernard JG. Sem Hop; 1969 Jan 26; 45(5):312-7. PubMed ID: 4307724 [No Abstract] [Full Text] [Related]
37. [Mental deterioration in arteriosclerotic subjects before and after treatment with SP 54 and with a placebo]. Buffa B, Cotta Ramusino M, Muti M. Riv Sper Freniatr Med Leg Alien Ment; 1969 Feb 28; 93(1):209-18. PubMed ID: 5402879 [No Abstract] [Full Text] [Related]
38. The effect of cyclandelate on mental function in patients with arteriosclerotic brain disease. Fine EW, Lewis D, Villa-Landa I, Blakemore CB. Br J Psychiatry; 1970 Aug 28; 117(537):157-61. PubMed ID: 4921174 [No Abstract] [Full Text] [Related]